10
NEWS
Dexcom G7 gets CE Mark
Dexcom's G7 is the next-generation continuous glucose
monitoring (CGM) system building on the best-selling
real-time CGM in the world. It is now more powerful
and easier to use with a small, all-in-one wearable and
completely redesigned mobile app. The new system will
have the fastest sensor warm-up on the market, with
no fingersticks or scanning required. Dexcom G7 builds
on the trusted performance of Dexcom CGM, which
is clinically proven to lower A1C, reduce hyper- and
hypoglycemia, and increase time in range (TIR).
The CE Mark (Conformité Européenne) for Dexcom
G7 CGM system for people with diabetes in Europe age
two years and older, includes use by pregnant women too.
It offers people with diabetes a better way to gain
greater control, managing it more confidently each day.
Its low-profile, all-in-one wearable sends real-time
glucose readings automatically to a compatible smart
device or receiver. It offers a suite of customizable alerts
that can warn of high or low glucose levels and help
users spend more time in range. Industry-leading remote
monitoring and reporting capabilities also allow them
to stay connected with their loved ones and care teams
anytime, anywhere.
"Today marks an incredible milestone for our
company and for people with diabetes in Europe," said
Kevin Sayer, chairman, president and CEO of Dexcom.
"This all-new platform offers an incredibly powerful CGM
that is simple to use, providing our users with insightful
glucose data on one screen that helps them spend less
time managing diabetes and more time doing the things
they love. Dexcom G7 takes everything people love about
G6 and makes it even better."
Dexcom expects to initiate a launch of Dexcom G7 in
Europe in the next weeks anad months. The company
also plans to introduce an updated CGM algorithm
in 2022, driving the next step forward in CGM sensor
performance.
Visit Dexcom.com and get started with Dexcom G6
today to experience the benefits of CGM now. To learn
more about Dexcom G7 and for additional information
about when it will be available in Europe, visit
Dexcom.com/G7